Levy Richard S
CIK 0001454983 Name as filed on the most recent filing
Filed as Levy Richard S (45)
110 transaction lines · from 45 filings · filed 2010-03-17 to 2026-05-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Madrigal Pharmaceuticals, Inc. 9 filings
- ISSUER Protara Therapeutics, Inc. 2 filings
- ISSUER Kodiak Sciences Inc. 1 filings
- ISSUER Incyte Corp 33 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
110 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2020-03-20 |
Kodiak Sciences Inc. KOD |
P, Open-market purchase | 250 acquired | 43.37 | 10,842.50 | Form 4, filing 0001209191-20-020949 | |
| 2017-08-23 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 1,793 acquired | 16.12 | 28,903.16 | Form 4, filing 0001179110-17-011806 | |
| 2017-08-23 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 100 acquired | 16.11 | 1,611.00 | Form 4, filing 0001179110-17-011806 | |
| 2017-08-23 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 100 acquired | 16.08 | 1,608.00 | Form 4, filing 0001179110-17-011806 | |
| 2017-08-23 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 7 acquired | 16.25 | 113.75 | Form 4, filing 0001179110-17-011806 | |
| 2017-08-22 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 2,944 acquired | 16.12 | 47,457.28 | Form 4, filing 0001179110-17-011766 | |
| 2017-08-22 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 389 acquired | 16.10 | 6,262.90 | Form 4, filing 0001179110-17-011766 | |
| 2017-08-22 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 127 acquired | 16.14 | 2,049.78 | Form 4, filing 0001179110-17-011766 | |
| 2017-08-22 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 90 acquired | 15.99 | 1,439.10 | Form 4, filing 0001179110-17-011766 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 900 acquired | 15.67 | 14,103.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 590 acquired | 16.09 | 9,493.10 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 440 acquired | 16.07 | 7,070.80 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 400 acquired | 15.80 | 6,320.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 210 acquired | 16.04 | 3,368.40 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 200 acquired | 16.02 | 3,204.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 200 acquired | 15.93 | 3,186.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 200 acquired | 15.79 | 3,158.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 200 acquired | 15.77 | 3,154.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 100 acquired | 15.72 | 1,572.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 100 acquired | 15.70 | 1,570.00 | Form 4, filing 0001179110-17-011725 | |
| 2017-08-21 |
Madrigal Pharmaceuticals, Inc. MDGL |
P, Open-market purchase | 10 acquired | 15.90 | 159.00 | Form 4, filing 0001179110-17-011725 | |
| 2016-01-06 |
Incyte Corp INCY |
S, Open-market sale | 3,937 disposed | 101.86 | 401,022.82 | Form 4, filing 0001209191-16-090542 | |
| 2015-12-07 |
Incyte Corp INCY |
S, Open-market sale | 3,937 disposed | 106.18 | 418,030.66 | Form 4, filing 0001209191-15-084255 | |
| 2015-11-06 |
Incyte Corp INCY |
S, Open-market sale | 3,936 disposed | 116.51 | 458,583.36 | Form 4, filing 0001209191-15-079453 | |
| 2015-10-06 |
Incyte Corp INCY |
S, Open-market sale | 3,937 disposed | 122.29 | 481,455.73 | Form 4, filing 0001209191-15-074840 | |
| 2015-09-11 |
Incyte Corp INCY |
S, Open-market sale | 4,301 disposed | 130.00 | 559,130.00 | Form 4, filing 0001209191-15-070756 | |
| 2015-09-08 |
Incyte Corp INCY |
S, Open-market sale | 3,937 disposed | 118.90 | 468,109.30 | Form 4, filing 0001209191-15-070143 | |
| 2015-08-06 |
Incyte Corp INCY |
S, Open-market sale | 3,936 disposed | 111.95 | 440,635.20 | Form 4, filing 0001209191-15-064903 | |
| 2015-07-15 |
Incyte Corp INCY |
S, Open-market sale | 70,217 disposed | 120.00 | 8,426,040.00 | Form 4, filing 0001209191-15-061181 | |
| 2015-07-06 |
Incyte Corp INCY |
S, Open-market sale | 3,937 disposed | 107.00 | 421,259.00 | Form 4, filing 0001209191-15-060140 | |
| 2015-06-19 |
Incyte Corp INCY |
S, Open-market sale | 20,000 disposed | 108.13 | 2,162,600.00 | Form 4, filing 0001209191-15-055681 | |
| 2015-06-08 |
Incyte Corp INCY |
S, Open-market sale | 3,937 disposed | 107.58 | 423,542.46 | Form 4, filing 0001209191-15-051893 | |
| 2015-05-06 |
Incyte Corp INCY |
S, Open-market sale | 7,412 disposed | 99.43 | 736,975.16 | Form 4, filing 0001209191-15-040494 | |
| 2015-04-06 |
Incyte Corp INCY |
S, Open-market sale | 25,000 disposed | 88.77 | 2,219,250.00 | Form 4, filing 0001209191-15-033126 | |
| 2015-03-06 |
Incyte Corp INCY |
S, Open-market sale | 25,000 disposed | 89.91 | 2,247,750.00 | Form 4, filing 0001209191-15-024720 | |
| 2015-02-17 |
Incyte Corp INCY |
S, Open-market sale | 12,000 disposed | 76.90 | 922,800.00 | Form 4, filing 0001209191-15-015509 | |
| 2015-02-06 |
Incyte Corp INCY |
S, Open-market sale | 25,000 disposed | 75.11 | 1,877,750.00 | Form 4, filing 0001209191-15-011382 | |
| 2015-01-16 |
Incyte Corp INCY |
S, Open-market sale | 12,000 disposed | 73.07 | 876,840.00 | Form 4, filing 0001209191-15-005231 | |
| 2015-01-06 |
Incyte Corp INCY |
S, Open-market sale | 25,000 disposed | 71.84 | 1,796,000.00 | Form 4, filing 0001209191-15-003207 | |
| 2014-12-16 |
Incyte Corp INCY |
S, Open-market sale | 12,000 disposed | 72.36 | 868,320.00 | Form 4, filing 0001181431-14-039189 | |
| 2014-11-17 |
Incyte Corp INCY |
S, Open-market sale | 12,000 disposed | 69.97 | 839,640.00 | Form 4, filing 0001181431-14-036855 | |
| 2014-10-16 |
Incyte Corp INCY |
S, Open-market sale | 8,000 disposed | 49.03 | 392,240.00 | Form 4, filing 0001181431-14-034515 | |
| 2014-09-16 |
Incyte Corp INCY |
S, Open-market sale | 8,000 disposed | 47.58 | 380,640.00 | Form 4, filing 0001181431-14-032285 | |
| 2014-08-18 |
Incyte Corp INCY |
S, Open-market sale | 8,000 disposed | 51.97 | 415,760.00 | Form 4, filing 0001181431-14-029717 | |
| 2014-07-16 |
Incyte Corp INCY |
S, Open-market sale | 8,000 disposed | 48.15 | 385,200.00 | Form 4, filing 0001181431-14-027050 | |
| 2014-06-16 |
Incyte Corp INCY |
S, Open-market sale | 8,000 disposed | 53.88 | 431,040.00 | Form 4, filing 0001181431-14-024372 | |
| 2014-05-16 |
Incyte Corp INCY |
S, Open-market sale | 8,000 disposed | 50.68 | 405,440.00 | Form 4, filing 0001181431-14-020393 | |
| 2014-02-14 |
Incyte Corp INCY |
S, Open-market sale | 39,787 disposed | 66.13 | 2,631,114.31 | Form 4, filing 0001181431-14-007429 | |
| 2014-02-13 |
Incyte Corp INCY |
S, Open-market sale | 191,309 disposed | 66.38 | 12,699,091.42 | Form 4, filing 0001181431-14-007429 | |
| 2013-09-06 |
Incyte Corp INCY |
S, Open-market sale | 25,000 disposed | 35.28 | 882,000.00 | Form 4, filing 0001181431-13-048228 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 24
- Open-market sale 86
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Levy Richard S, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001454983
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6